Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on chiral resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107778194B details a high-yield phenylalanine ester synthesis. This route offers significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN114044777A reveals a cost-effective route for Ruxolitinib Phosphate using Nickel catalysis and chiral resolution, offering high purity and scalable manufacturing for global supply chains.
Advanced resolution method achieving >99% ee for S-3-cyclohexenecarboxylic acid, optimizing Edoxaban intermediate supply chains with cost-effective recycling.
Patent CN109912624B reveals a streamlined synthesis for Baloxavir key intermediates, offering significant cost reduction and improved supply chain reliability for pharmaceutical manufacturers.
Patent CN101570492B details a high-yield ephedrine synthesis route reducing solvent use and environmental impact for scalable pharmaceutical manufacturing supply chains.
Patent CN109761886B reveals a superior resolution method for Argatroban intermediates using D-(+)-dibenzoyltartaric acid, achieving 99.1% optical purity and enhanced manufacturing efficiency.
Advanced preparation method for Tofacitinib intermediates featuring superior enantiomeric control and optimized hydrogenation for reliable pharmaceutical supply chains.
Discover the patented CN111356682A method for producing (2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethane-1-ol. Enhanced yield, safety, and cost efficiency for API manufacturing.
Patent CN102363599A reveals a robust chiral resolution method for sitagliptin intermediates using D-di-p-toluoyl tartrate, offering significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Novel resolution and inversion method for Boc-3-hydroxypiperidine. Industrial scale production with high ee. Reliable pharmaceutical intermediate supplier.
Patented hydrogen-bond resolution method for 2,3:6,7-dibenzobicyclo[3.3.1]octa-2,6-diene-4,8-dione. Achieves 99.9% ee and 55% total yield, offering superior cost efficiency for pharmaceutical manufacturing.
Patent CN111763209B details a novel Ruxolitinib synthesis avoiding expensive catalysts. Discover cost reduction in API manufacturing and high-purity pharmaceutical intermediates.
Novel chiral resolution process for high-purity Salbutamol Sulfate offering cost reduction and supply reliability for pharmaceutical manufacturing partners globally.
Patent CN1622944A details a safer reductive amination route for chroman derivatives, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN1204130C details a novel chiral resolution process for tetrahydrofuran carboxylic acid intermediates offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally.
Novel method for CPL-active spiroalkenes via Pd-catalyzed coupling and thermal aromatization ensures high stability and yield for display materials.
Patent CN1305460A reveals a novel resolution process using L-pyroglutamic acid for high-purity tetrahydrocarbazole intermediates, offering significant cost and supply chain advantages.
Patent CN101003549B discloses a robust synthesis of planar chiral [2.2]paracyclophane phosphines via cyclopalladium resolution, offering high stability for pharmaceutical intermediates.
Novel chiral resolution route for high-purity tetrahydroisoquinoline intermediates. Cost-effective, scalable process for peptide drug synthesis.
Novel resolution method for cis-chiral intermediate. Reduces cost and improves scalability for pharmaceutical manufacturing supply chains.